BioNTech (BNTX) News Today $111.66 +0.31 (+0.28%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$111.44 -0.22 (-0.20%) As of 08/8/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is BioNTech Up Today?Toggle Visibility of Why Is BioNTech Up Today?BioNTech SE Sponsored ADR (NASDAQ:BNTX) saw its shares move higher today after a string of positive analyst actions and robust mid-year performance, even as it settles a major patent dispute. Key developments include: Positive Sentiment: Evercore ISI upgraded BNTX to a Buy, citing confidence in its growth trajectory BioNTech SE (BNTX) Gets a Buy from Evercore ISI Positive Sentiment: Strong mid-2025 financial results beat expectations, underpinning revenue growth and margin expansion BioNTech SE Reports Strong Financial Results for Mid-2025 Positive Sentiment: Early data from the GEN1056 tumor-treatment study with Genmab show promising results, bolstering the pipeline BioNTech and Genmab’s GEN1056 Study: A New Hope for Advanced Tumor Treatment Positive Sentiment: Wells Fargo analysts raised their price target to $150, reflecting optimism on long-term prospects Wells Fargo & Company Analysts Give BioNTech (NASDAQ:BNTX) a $150.00 Price Target Positive Sentiment: Bank of America set a new $134 price target, signaling upgraded earnings forecasts BioNTech (NASDAQ:BNTX) Given New $134.00 Price Target at Bank of America Positive Sentiment: Consensus analysts’ target rose to $136.58, indicating broad investor confidence Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $136.58 Neutral Sentiment: Goldman Sachs maintained a Hold rating, suggesting a wait-and-see approach Goldman Sachs Sticks to Its Hold Rating for BioNTech SE (BNTX) Neutral Sentiment: GSK provided an update on the U.S. settlement in the CureVac/BioNTech mRNA litigation, clarifying deal terms GSK provides update on U.S. settlement CureVac/BioNTech mRNA patent litigation Neutral Sentiment: Q2 earnings and updated analyst estimates are now live, offering detailed guidance revisions BioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates Neutral Sentiment: Reuters reports that CureVac has settled patent litigation with Pfizer and BioNTech, ending a multi-year dispute CureVac settles patent dispute litigation with Pfizer and BioNTech Negative Sentiment: BioNTech agreed to pay US$370 million to CureVac to resolve the mRNA patent dispute, a sizable one-time charge BioNTech (BNTX) Settles mRNA Patent Dispute with CureVac for US$370 Million Posted 9h agoAI Generated. May Contain Errors. BNTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Goldman Sachs Sticks to Its Hold Rating for BioNTech SE (BNTX)August 8 at 3:19 PM | theglobeandmail.comBioNTech (BNTX) Settles mRNA Patent Dispute with CureVac for US$370 MillionAugust 8 at 3:19 PM | finance.yahoo.comBioNTech SE (BNTX) Gets a Buy from Evercore ISIAugust 8 at 10:17 AM | theglobeandmail.comBioNTech SE Reports Strong Financial Results for Mid-2025August 8 at 10:17 AM | theglobeandmail.comBioNTech and Genmab’s GEN1056 Study: A New Hope for Advanced Tumor TreatmentAugust 8 at 10:17 AM | msn.comGSK provides update on U.S. settlement CureVac/BioNTech mRNA patent litigationAugust 8 at 10:17 AM | msn.comBioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their EstimatesAugust 8 at 10:17 AM | finance.yahoo.comWells Fargo & Company Analysts Give BioNTech (NASDAQ:BNTX) a $150.00 Price TargetAugust 8 at 3:03 AM | americanbankingnews.comCureVac settles patent dispute litigation with Pfizer and BioNTechAugust 7 at 9:00 PM | reuters.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CAAugust 7 at 5:39 AM | marketbeat.comBioNTech (NASDAQ:BNTX) Given New $134.00 Price Target at Bank of AmericaAugust 7 at 3:39 AM | americanbankingnews.comAnalysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $136.58August 7 at 2:45 AM | americanbankingnews.comWells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $150.00August 6 at 11:07 AM | marketbeat.comBioNTech (NASDAQ:BNTX) Stock Price Expected to Rise, Bank of America Analyst SaysAugust 6 at 11:07 AM | marketbeat.comBioNTech price target raised to $185 from $181 at Clear StreetAugust 5, 2025 | finance.yahoo.comThese Analysts Revise Their Forecasts On BioNTech After Q2 ResultsAugust 5, 2025 | benzinga.comBioNTech (BNTX) Reports Increased Sales And Reduced Losses In Q2 2025August 5, 2025 | finance.yahoo.comBioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results, Misses Estimates By $0.44 EPSAugust 5, 2025 | marketbeat.comTD Asset Management Inc Trims Stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 5, 2025 | marketbeat.comBioNTech SE (BNTX) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comBioNTech SE 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.comBioNTech shares climb over 2% as Q2 revenue doubles, Bristol Myers partnership boosts outlookAugust 4, 2025 | msn.comBIT Capital GmbH Sells 8,894 Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 4, 2025 | marketbeat.comBioNTech posts Q2 beat as revenue more than doublesAugust 4, 2025 | msn.comBioNTech Stock Rises as Drug Maker Beats Earnings Expectations.August 4, 2025 | barrons.comBioNTech's Q2 revenues double on higher COVID vaccine salesAugust 4, 2025 | reuters.comBioNTech Announces Second Quarter 2025 Financial Results and Corporate UpdateAugust 4, 2025 | globenewswire.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Stake Reduced by Scotia Capital Inc.August 4, 2025 | marketbeat.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Shares Sold by Envestnet Asset Management Inc.August 4, 2025 | marketbeat.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from BrokeragesAugust 4, 2025 | marketbeat.comBioNTech Q2 2025 Earnings PreviewAugust 1, 2025 | msn.com2BNTX : A Look Ahead: BioNTech's Earnings ForecastAugust 1, 2025 | benzinga.comPfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent winAugust 1, 2025 | reuters.comPandemic darlings Moderna, BioNTech are now on two different pathsJuly 31, 2025 | cnbc.comHarvest Fund Management Co. Ltd Invests $227,000 in BioNTech SE Sponsored ADR (NASDAQ:BNTX)July 31, 2025 | marketbeat.comBaader Bank Aktiengesellschaft Boosts Stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX)July 30, 2025 | marketbeat.comDecheng Capital LLC Decreases Stock Holdings in BioNTech SE Sponsored ADR (NASDAQ:BNTX)July 30, 2025 | marketbeat.comBioNTech (BNTX) to Release Quarterly Earnings on MondayJuly 28, 2025 | marketbeat.comAllianz Asset Management GmbH Buys 37,075 Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX)July 27, 2025 | marketbeat.comCerity Partners LLC Invests $357,000 in BioNTech SE Sponsored ADR (NASDAQ:BNTX)July 27, 2025 | marketbeat.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Holdings Cut by Baillie Gifford & Co.July 26, 2025 | marketbeat.comPfizer/BioNTech, Moderna win EU backing for updated COVID shotsJuly 25, 2025 | msn.comPfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European UnionJuly 25, 2025 | businesswire.comPfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European UnionJuly 25, 2025 | globenewswire.comBank Julius Baer & Co. Ltd Zurich Sells 2,504 Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX)July 24, 2025 | marketbeat.com8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling GrowthJuly 23, 2025 | globenewswire.comBioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025July 21, 2025 | globenewswire.comRyan Richardson Departs BioNTech (BNTX), A Pillar In US$1 Billion Capital RaisesJuly 17, 2025 | finance.yahoo.comBioNTech Announces Ryan Richardson to Step Down from the Management BoardJuly 17, 2025 | globenewswire.comBreaking Down BioNTech: 12 Analysts Share Their ViewsJuly 16, 2025 | benzinga.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.300.38▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼3412▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Summit Therapeutics News Today Insmed News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTX Stock Alerts